Brazil questions transparency in Chinese coronavirus vaccine ‘emergency use’ approval

▴ Brazil questions transparency in Chinese coronavirus vaccine ‘emergency use’ approval
Brazilian health regulator Anvisa has said that Chinese health authorities had not been transparent in approving its COVID-19 vaccine ‘CoronaVac’ for emergency use.

CoronaVac, produced by the Chinese private laboratory Sinovac is currently undergoing phase 3 clinical trials in Sao Paulo.

The health regulator in a statement noted that while the vaccine has had an emergency use authorization in China since June, the country’s authorities have not been transparent about the criteria used for granting this authorization. Brazilian President Jair Bolsonaro has repeatedly cast doubt on the CoronaVac vaccine.

Sao Paulo Governor Joao Doria said the state expected to start vaccinating its residents in January, though Brazil’s most populous state will not be able to use CoronaVac until it is approved by Anvisa. China’s foreign ministry spokesman Wang Wenbin defended Coronavac’s development process, saying some countries had approved Chinese inoculations and termed it as a demonstration of the safety and effectiveness of China's vaccines.

As per reports, tens of thousands of people have taken the Sinovac vaccine in China’s emergency-use program that was approved for limited groups of high-risk category people.

Little information is publicly available about the approval process, scope, size, and scientific merit of the emergency-use program. Experts have raised concerns about safety and efficacy, both from a legal as well as ethical standpoint.

China has defended the use of experimental vaccines in this way saying the move was sanctioned by the World Health Organization (WHO).

Tags : #Brazil #LatestCOVIDVaccineNews17thDec #UnitetoFightCorona #LatestPharmaNews17thDec #China #Sinovac #Anvisa #WHO

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024